SpyGlass Pharma, Inc. Common Stock
SGP
Rank in Stocks
#8274
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to... SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
Share Price
$32.88
Last synced: 2026-11-13
Market Cap
$1.10B
Change (1 day)
-1.32%
Change (1 year)
-
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade SpyGlass Pharma, Inc. Common Stock (SGP)
Category
Healthcare
EPS for SpyGlass Pharma, Inc. Common Stock (SGP)
EPS as of June 2026 TTM: $-1.66
According to SpyGlass Pharma, Inc. Common Stock's latest financial reports, its current EPS (TTM) is $-1.66. At the end of 2026 the company had an EPS of 0, equal to its 2026 EPS of 0.
EPS history for SpyGlass Pharma, Inc. Common Stock from 2025 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.66 | 32.80% |
| 2025 | $-1.25 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.99 | -40.36% |
US
|
|
| $15.66 | -1,043.37% |
US
|
|
| $-7.07 | 325.90% |
US
|
|
| $-5.29 | 218.67% |
AU
|
|
| $12.88 | -875.91% |
BE
|
Questions about SpyGlass Pharma, Inc. Common Stock's earnings per share (EPS)
What is SpyGlass Pharma, Inc. Common Stock's earnings per share (EPS)?
SpyGlass Pharma, Inc. Common Stock's earnings per share (EPS) over the last twelve months is $-1.66, as of Jun 2026.
How does SpyGlass Pharma, Inc. Common Stock's earnings per share (EPS) compare with similar companies?
SpyGlass Pharma, Inc. Common Stock's earnings per share (EPS) ($-1.66) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.